TO THE EDITOR—We welcome with great interest a randomized controlled trial to evaluate the efficacy of doxycycline prophylaxis for sexually transmitted infections (STIs) as proposed by Boyd et al [1, 2], although we offer several concerns: Syphilis is readily treatable and curable; doxycycline prophylaxis, therefore, would be considered an alternative to guideline-recommended quarterly testing ...
